Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TVINGSTRUP DYREKLINIK A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.8% 9.5% 8.0% 4.3% 4.2% 3.2% 12.0% 11.7%   Credit score (0-100)   46 26 29 47 48 56 20 20   Credit rating   BBB BB BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,203 4,626 5,262 5,470 6,896 6,870 0.0 0.0   EBITDA   370 169 1,378 1,062 789 1,414 0.0 0.0   EBIT   212 -1.7 1,244 904 661 1,260 0.0 0.0   Pre-tax profit (PTP)   228.3 9.8 1,241.4 886.4 664.2 1,260.5 0.0 0.0   Net earnings   178.7 7.3 968.1 688.4 518.5 982.7 0.0 0.0   Pre-tax profit without non-rec. items   228 9.8 1,241 886 664 1,261 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   548 320 467 368 311 653 0.0 0.0   Shareholders equity total   1,618 609 1,577 2,029 2,027 2,610 1,810 1,810   Interest-bearing liabilities   14.4 852 0.0 0.0 7.2 0.0 0.0 0.0   Balance sheet total (assets)   3,250 3,266 3,492 3,415 3,465 3,656 1,810 1,810   Net Debt   -1,455 -919 -1,763 -1,970 -1,867 -1,903 -1,810 -1,810     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,203 4,626 5,262 5,470 6,896 6,870 0.0 0.0   Gross profit growth   19.0% -11.1% 13.7% 3.9% 26.1% -0.4% -100.0% 0.0%   Employees   10 10 11 11 13 14 0 0   Employee growth %   0.0% 0.0% 10.0% 0.0% 18.2% 7.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,250 3,266 3,492 3,415 3,465 3,656 1,810 1,810   Balance sheet change%   14.4% 0.5% 6.9% -2.2% 1.5% 5.5% -50.5% 0.0%   Added value   370.1 169.0 1,377.8 1,061.8 819.1 1,413.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -71 -398 12 -256 -185 188 -653 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   4.1% -0.0% 23.6% 16.5% 9.6% 18.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.5% 0.3% 37.1% 26.3% 19.3% 35.4% 0.0% 0.0%   ROI %   14.4% 0.7% 82.5% 50.4% 32.7% 54.1% 0.0% 0.0%   ROE %   11.7% 0.7% 88.6% 38.2% 25.6% 42.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   49.8% 18.7% 45.2% 59.4% 58.5% 71.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -393.1% -544.1% -128.0% -185.5% -236.6% -134.6% 0.0% 0.0%   Gearing %   0.9% 139.9% 0.0% 0.0% 0.4% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.4% 0.2% 2.7% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.3 0.9 1.2 1.7 1.8 2.2 0.0 0.0   Current Ratio   1.8 1.1 1.6 2.2 2.2 2.9 0.0 0.0   Cash and cash equivalent   1,469.4 1,771.8 1,762.9 1,969.7 1,874.0 1,903.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,141.2 263.9 1,085.6 1,636.0 1,691.6 1,946.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   37 17 125 97 63 101 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   37 17 125 97 61 101 0 0   EBIT / employee   21 -0 113 82 51 90 0 0   Net earnings / employee   18 1 88 63 40 70 0 0